Page last updated: 2024-08-07 15:59:27
Matrix metalloproteinase-9
A matrix metalloproteinase-9 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P14780]
Synonyms
MMP-9;
EC 3.4.24.35;
92 kDa gelatinase;
92 kDa type IV collagenase;
Gelatinase B;
GELB
Research
Bioassay Publications (91)
Timeframe | Studies on this Protein(%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (8.79) | 18.2507 |
2000's | 44 (48.35) | 29.6817 |
2010's | 32 (35.16) | 24.3611 |
2020's | 7 (7.69) | 2.80 |
Compounds (66)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
---|---|---|---|---|---|
catechol | Homo sapiens (human) | IC50 | 23.3670 | 1 | 0 |
busulfan | Homo sapiens (human) | IC50 | 5.2150 | 1 | 0 |
econazole | Homo sapiens (human) | IC50 | 6.9970 | 1 | 0 |
way 151693 | Homo sapiens (human) | IC50 | 0.0057 | 5 | 7 |
nafamostat | Homo sapiens (human) | IC50 | 420.0000 | 1 | 1 |
prazosin | Homo sapiens (human) | IC50 | 6.9630 | 1 | 0 |
secobarbital | Homo sapiens (human) | IC50 | 2.6430 | 1 | 0 |
clodronic acid | Homo sapiens (human) | IC50 | 320.0000 | 1 | 1 |
tiludronic acid | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
5,5'-methylenedisalicylic acid | Homo sapiens (human) | IC50 | 43.4000 | 1 | 1 |
zoledronic acid | Homo sapiens (human) | IC50 | 52.0000 | 1 | 1 |
piloty's acid | Homo sapiens (human) | Ki | 56.3100 | 3 | 10 |
aminoquinuride | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
marimastat | Homo sapiens (human) | IC50 | 1.0818 | 10 | 10 |
marimastat | Homo sapiens (human) | Ki | 0.0077 | 3 | 3 |
n-(2-isobutyl-3-(n'-hydroxycarbonylamido)propanoyl)-o-methyltyrosinemethylamide | Homo sapiens (human) | Ki | 0.0010 | 1 | 1 |
ilomastat | Homo sapiens (human) | IC50 | 0.0034 | 12 | 12 |
ilomastat | Homo sapiens (human) | Ki | 0.0004 | 2 | 2 |
procyanidin C1 | Homo sapiens (human) | IC50 | 53.2000 | 1 | 1 |
3-((benzyl)(methylaminocarbonyl)methylaminocarbonyl)n-hydroxy-5-methylhexanamide | Homo sapiens (human) | IC50 | 0.0004 | 1 | 1 |
2-(4-aminophenyl)benzothiazole | Homo sapiens (human) | IC50 | 79.0000 | 1 | 1 |
taxifolin | Homo sapiens (human) | IC50 | 32.0200 | 1 | 1 |
cgs 27023a | Homo sapiens (human) | IC50 | 0.0191 | 5 | 7 |
cgs 27023a | Homo sapiens (human) | Ki | 0.0211 | 2 | 5 |
prinomastat | Homo sapiens (human) | IC50 | 0.0007 | 6 | 6 |
isoliquiritigenin | Homo sapiens (human) | IC50 | 0.0100 | 1 | 1 |
2-[(4-phenylphenyl)sulfonylamino]pentanedioic acid | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
caffeic acid | Homo sapiens (human) | IC50 | 0.0156 | 2 | 2 |
rs-130830 | Homo sapiens (human) | IC50 | 0.0463 | 6 | 8 |
rs-130830 | Homo sapiens (human) | Ki | 0.0914 | 4 | 9 |
quercetin | Homo sapiens (human) | IC50 | 0.8919 | 2 | 2 |
luteolin | Homo sapiens (human) | IC50 | 5.6200 | 1 | 1 |
pulmicort | Homo sapiens (human) | IC50 | 1.9890 | 1 | 0 |
amentoflavone | Homo sapiens (human) | IC50 | 2.5800 | 1 | 1 |
mangiferin | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
robustaflavone | Homo sapiens (human) | IC50 | 11.8500 | 1 | 1 |
tmi-1 | Homo sapiens (human) | IC50 | 0.0130 | 1 | 6 |
benzyloxycarbonyl-phe-ala-fluormethylketone | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
bilobetin | Homo sapiens (human) | IC50 | 10.3300 | 1 | 1 |
batimastat | Homo sapiens (human) | IC50 | 0.0066 | 4 | 4 |
isoacteoside | Homo sapiens (human) | IC50 | 14.2800 | 1 | 1 |
Methyl rosmarinate | Homo sapiens (human) | IC50 | 0.6100 | 1 | 1 |
ik 682 | Homo sapiens (human) | IC50 | 10.3400 | 1 | 1 |
ik 682 | Homo sapiens (human) | Ki | 10.3400 | 2 | 2 |
bay 12-9566 | Homo sapiens (human) | IC50 | 0.3010 | 1 | 1 |
bay 12-9566 | Homo sapiens (human) | Ki | 0.3010 | 1 | 1 |
chlorhexidine | Homo sapiens (human) | IC50 | 7.6300 | 1 | 1 |
(11c)cgs 25966 | Homo sapiens (human) | IC50 | 0.0080 | 1 | 1 |
(11c)cgs 25966 | Homo sapiens (human) | Ki | 0.0246 | 5 | 5 |
bb-78485 | Homo sapiens (human) | IC50 | 0.0972 | 1 | 1 |
ro 32-3555 | Homo sapiens (human) | IC50 | 0.0304 | 3 | 5 |
ro 32-3555 | Homo sapiens (human) | Ki | 0.0298 | 2 | 2 |
ro 28-2653 | Homo sapiens (human) | IC50 | 0.0070 | 1 | 1 |
abt-770 | Homo sapiens (human) | IC50 | 0.1200 | 3 | 3 |
sb 3ct compound | Homo sapiens (human) | Ki | 0.5333 | 6 | 6 |
pd 166793 | Homo sapiens (human) | IC50 | 7.9216 | 2 | 2 |
sc 78080 | Homo sapiens (human) | IC50 | 0.0002 | 2 | 2 |
ro 31-9790 | Homo sapiens (human) | IC50 | 0.0120 | 2 | 2 |
ro 31-9790 | Homo sapiens (human) | Ki | 0.0020 | 1 | 1 |
n-((2s)-2-mercapto-1-oxo-4-(3,4,4- trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-l-leucyl-n,3- dimethyl-l-valinamide | Homo sapiens (human) | IC50 | 0.0250 | 1 | 1 |
arp-100 | Homo sapiens (human) | IC50 | 0.2000 | 6 | 6 |
kb r8301 | Homo sapiens (human) | IC50 | 0.0003 | 1 | 1 |
s 3304 | Homo sapiens (human) | IC50 | 0.0163 | 2 | 2 |
N(2)-([biphenyl]-4-ylsulfonyl)-N-hydroxy-N(2)-isopropoxy-D-valinamide | Homo sapiens (human) | IC50 | 0.0067 | 3 | 3 |
bms-566394 | Homo sapiens (human) | Ki | 6.0640 | 2 | 2 |
ks370g | Homo sapiens (human) | IC50 | 0.0073 | 1 | 1 |
incb3619 | Homo sapiens (human) | IC50 | 0.3660 | 2 | 2 |
tosedostat | Homo sapiens (human) | IC50 | 1.5000 | 1 | 1 |
grassystatin a | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
minocycline | Homo sapiens (human) | IC50 | 180.0000 | 1 | 1 |
dacarbazine | Homo sapiens (human) | IC50 | 0.5560 | 1 | 0 |
2-[(4-chlorophenyl)methylthio]-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-4-one | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
2-[(4-methoxyphenyl)methylthio]-6-methyl-1H-pyrimidin-4-one | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
hydrazinocurcumin | Homo sapiens (human) | IC50 | 19.4000 | 1 | 1 |
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
---|---|---|---|---|---|
amentoflavone | Homo sapiens (human) | Kd | 2.1800 | 1 | 1 |
MMP-9-IN-1 | Homo sapiens (human) | Kd | 2.1000 | 1 | 1 |
Enables
This protein enables 9 target(s):
Target | Category | Definition |
---|---|---|
endopeptidase activity | molecular function | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain. [http://merops.sanger.ac.uk/about/glossary.htm#ENDOPEPTIDASE] |
metalloendopeptidase activity | molecular function | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions. [GOC:mah, https://www.ebi.ac.uk/merops/about/glossary.shtml#CATTYPE, https://www.ebi.ac.uk/merops/about/glossary.shtml#ENDOPEPTIDASE] |
serine-type endopeptidase activity | molecular function | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine). [GOC:mah, https://www.ebi.ac.uk/merops/about/glossary.shtml#CATTYPE] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
collagen binding | molecular function | Binding to collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%). [GOC:ai, ISBN:0198506732] |
peptidase activity | molecular function | Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid. [GOC:jl, ISBN:0815332181] |
metallopeptidase activity | molecular function | Catalysis of the hydrolysis of peptide bonds by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions. [GOC:mah, https://www.ebi.ac.uk/merops/about/glossary.shtml#CATTYPE] |
zinc ion binding | molecular function | Binding to a zinc ion (Zn). [GOC:ai] |
identical protein binding | molecular function | Binding to an identical protein or proteins. [GOC:jl] |
Located In
This protein is located in 6 target(s):
Target | Category | Definition |
---|---|---|
extracellular region | cellular component | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. [GOC:go_curators] |
extracellular space | cellular component | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. [ISBN:0198547684] |
collagen-containing extracellular matrix | cellular component | An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells. [GOC:BHF, GOC:rph, PMID:21123617] |
extracellular exosome | cellular component | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. [GOC:BHF, GOC:mah, GOC:vesicles, PMID:15908444, PMID:17641064, PMID:19442504, PMID:19498381, PMID:22418571, PMID:24009894] |
tertiary granule lumen | cellular component | Any membrane-enclosed lumen that is part of a tertiary granule. [GO_REF:0000064, GOC:TermGenie, PMID:23650620] |
ficolin-1-rich granule lumen | cellular component | Any membrane-enclosed lumen that is part of a ficolin-1-rich granule. [GO_REF:0000064, GOC:TermGenie, PMID:23650620] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
---|---|---|
extracellular space | cellular component | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. [ISBN:0198547684] |
Involved In
This protein is involved in 30 target(s):
Target | Category | Definition |
---|---|---|
skeletal system development | biological process | The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton). [GOC:dph, GOC:jid, GOC:tb] |
positive regulation of protein phosphorylation | biological process | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. [GOC:hjd] |
proteolysis | biological process | The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. [GOC:bf, GOC:mah] |
apoptotic process | biological process | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. [GOC:cjm, GOC:dhl, GOC:ecd, GOC:go_curators, GOC:mtg_apoptosis, GOC:tb, ISBN:0198506732, PMID:18846107, PMID:21494263] |
embryo implantation | biological process | Attachment of the blastocyst to the uterine lining. [GOC:isa_complete, http://www.medterms.com] |
cell migration | biological process | The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. [GOC:cjm, GOC:dph, GOC:ems, GOC:pf, Wikipedia:Cell_migration] |
extracellular matrix disassembly | biological process | A process that results in the breakdown of the extracellular matrix. [GOC:jid] |
macrophage differentiation | biological process | The process in which a relatively unspecialized monocyte acquires the specialized features of a macrophage. [GOC:add, ISBN:0781735149] |
collagen catabolic process | biological process | The proteolytic chemical reactions and pathways resulting in the breakdown of collagen in the extracellular matrix, usually carried out by proteases secreted by nearby cells. [GOC:mah, ISBN:0815316194] |
cellular response to reactive oxygen species | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals. [GOC:mah] |
endodermal cell differentiation | biological process | The process in which a relatively unspecialized cell acquires the specialized features of an endoderm cell, a cell of the inner of the three germ layers of the embryo. [CL:0000223, GOC:yaf, PMID:17624332] |
positive regulation of apoptotic process | biological process | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. [GOC:jl, GOC:mtg_apoptosis] |
negative regulation of apoptotic process | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. [GOC:jl, GOC:mtg_apoptosis] |
positive regulation of DNA binding | biological process | Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid). [GOC:dph, GOC:jl, GOC:tb] |
positive regulation of epidermal growth factor receptor signaling pathway | biological process | Any process that activates or increases the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity. [GOC:go_curators] |
ephrin receptor signaling pathway | biological process | The series of molecular signals initiated by ephrin binding to its receptor, and ending with the regulation of a downstream cellular process, e.g. transcription. [GOC:ceb] |
positive regulation of keratinocyte migration | biological process | Any process that activates or increases the frequency, rate or extent of keratinocyte migration. [GOC:ai] |
cellular response to lipopolysaccharide | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. [GOC:mah] |
cellular response to cadmium ion | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus. [GOC:mah] |
cellular response to UV-A | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a UV-A radiation stimulus. UV-A radiation (UV-A light) spans the wavelengths 315 to 400 nm. [GOC:mah] |
positive regulation of release of cytochrome c from mitochondria | biological process | Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation. [GOC:BHF, GOC:dph, GOC:mtg_apoptosis, GOC:tb] |
regulation of neuroinflammatory response | biological process | Any process that modulates the frequency, rate or extent of neuroinflammatory response. [GOC:aruk, GOC:bc, PMID:10981966, PMID:11099416, PMID:18164423] |
positive regulation of receptor binding | biological process | Any process that activates or increases the frequency, rate or extent of a protein or other molecule binding to a receptor. [GOC:signaling, GOC:TermGenie] |
response to amyloid-beta | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a amyloid-beta stimulus. [GO_REF:0000071, GOC:TermGenie, PMID:23555824] |
positive regulation of vascular associated smooth muscle cell proliferation | biological process | Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation. [GO_REF:0000058, GOC:TermGenie, PMID:23246467] |
negative regulation of epithelial cell differentiation involved in kidney development | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of epithelial cell differentiation involved in kidney development. [GOC:mtg_kidney_jan10, GOC:yaf] |
negative regulation of intrinsic apoptotic signaling pathway | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway. [GOC:mtg_apoptosis] |
negative regulation of cation channel activity | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of cation channel activity. [GOC:BHF] |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway. [GOC:mtg_apoptosis] |
extracellular matrix organization | biological process | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix. [GOC:mah] |